ISMPP West 2022
Oxford PharmaGenesis is proud to sponsor ISMPP West 2022. On this page you can find information about our award-winning work and white papers, leaflets and more.
Featured
24 January 2024
ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
All
- All
- News
- Articles
- Events
'The opportunities are there to take': Executive Director Catherine Hill discusses her journey as a woman in a leadership role at Oxford PharmaGenesis
Thanks to colleagues who took part in the 2022 Great Place to Work survey, Oxford PharmaGenesis is ranked the UK’s no. 6 Best Workplace for Women (large company category). Executive Director Catherine Hill sits on the Oxford PharmaGenesis Board and co-leads the Regional Leadership Team for Europe. Here, she tells us about her own journey…
Working in and around #MedComms Careers Event
Do you want to feel valued for who you really are? Oxford PharmaGenesis will be at the Working in and around #MedComms careers event! Whether you’re new to medical communications or looking to advance your career, we want to hear about your unique skills and experience. Visit our booth to chat about our award-winning HealthScience consultancy, plus our exciting roles, development opportunities and one-of-a-kind company culture.
Supporting research at the University of Oxford: Oxford PharmaGenesis funds studentship at Green Templeton College to explore the impact of race and ethnicity on emerging digital techniques in dermatology
Oxford PharmaGenesis is delighted to support a funded DPhil studentship in Translational Health Sciences in collaboration with Green Templeton College at the University of Oxford, UK. The studentship will examine the importance of diversity in dermatology, particularly when applying emerging techniques in artificial intelligence and machine learning. Applications are now open. Please help to spread…
The MM+M Agency 100 report: Oxford PharmaGenesis recognized as industry leader for the second year running
For the second year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.
Promoting diversity in clinical trials: Oxford PharmaGenesis sponsors latest CISCRP campaign
Oxford PharmaGenesis is proud to sponsor the latest CISCRP clinical trials education campaign to raise awareness and understanding of clinical research among minority urban communities in cities across the USA and among the wider general public.
